2013
SEDIS SARL is founded
The company is set up to supply, install and maintain medical devices in West Africa, working closely with hospitals, laboratories and procurement agencies.
Products
Infusion fluids, medicines, nutrition, medical devices and animal health.
Explore this section
About
From hands-on experience in the medical sector to the creation of a local pharmaceutical industry.
2013
first steps in the medical sector in West Africa
2023
SEDIS SARL becomes TILAMED PHARMA SA
6
approvals, authorisations and certificates obtained
2ha
industrial site in Sèmè-Podji
Key milestones
2013
The company is set up to supply, install and maintain medical devices in West Africa, working closely with hospitals, laboratories and procurement agencies.
2013 – 2022
In Benin, no injectable solution is manufactured locally. Market studies and meetings with health authorities, procurement agencies and European equipment manufacturers: the industrial project takes shape.
2023
SEDIS SARL becomes TILAMED PHARMA SA, a public limited company with a share capital of one billion CFA francs, focused on industrial production.
16 May 2023
Meeting in committee, the Benin Pharmaceutical Regulatory Agency issues a favourable opinion on the opening and operation of a pharmaceutical plant.
30 June 2023
The installation and operation of the pharmaceutical plant are authorised.
Reference No. 1138 ABRP/DHE/DAE/SA · 30 June 2023 · Benin Pharmaceutical Regulatory Agency and Ministry of Health
7 August 2024
The project is recognised as compliant with environmental and social requirements.
Reference Order No. 0253/MCVT/DC/SGM/DG-ABE/DEES/SEIES/SA · 7 August 2024 · Ministry of Health and Ministry of the Environment
9 September 2024
TILAMED Pharma's industrial activity is authorised.
Reference No. LFFL EK3V JE3W CQ9Z · 9 September 2024 · Ministry of Trade and Industry
28 October 2024
The list of tax-exempt production equipment is set.
Reference No. 712/APIEX/DEAPI/SETAPI/SA · 28 October 2024 · Investment and Export Promotion Agency (APIEX)
28 November 2024
The project is governed by ministerial order and benefits from a tax and social-security exemption (regime B, 8 years) for its investment and operating phases.
Reference No. 034/MDC/MEF/MIC/DC/SGM/DDI/SA/041SGG24 · 28 November 2024 · Government of the Republic of Benin
9 September 2025
The State of Benin entrusts TILAMED PHARMA SA with a 2-hectare industrial site, under a long-term lease, in the Sèmè-Podji industrial zone on the Nigerian border.
Reference Long-term lease No. 2494/MEF/DC/SGM/ANDF/DAJuF/DGDE/S
TodayIn progress
TILAMED Pharma is preparing its injectable-solutions production unit in the Sèmè-Podji special economic zone.
TomorrowNext step
Start of production and recruitment of the first teams.
Our locations
Sèmè-Podji · Benin
2 hectares (20,000 m²) in the Sèmè-Podji industrial zone, on the Nigerian border.
The Sèmè-Podji siteCotonou · Benin
An office building in Les Cocotiers, in the city centre, owned by TILAMED PHARMA SA.
Our officesOuagadougou · Burkina Faso
A 1,000 m² office building in Dassasgho.
Our offices